Related Experiment Video
Updated: Mar 24, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Population-based Surveillance for Medically Attended Human Parainfluenza Viruses From the Influenza Incidence
Andrea Steffens1, Lyn Finelli, Brett Whitaker
1From the *Influenza Division, and †Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Insights
Parainfluenza viruses (PIV) significantly impact pediatric outpatient visits for influenza-like illness (ILI). PIV types 1-3 are common, especially in children under 5, with varying seasonal patterns.
Area of Science:
- Pediatric Infectious Diseases
- Respiratory Virology
- Public Health Surveillance
Background:
- Parainfluenza viruses (PIV) are a known cause of pediatric hospitalizations in the U.S.
- No systematic surveillance data existed for PIV burden in pediatric outpatients.
Purpose of the Study:
- To estimate the burden of parainfluenza virus (PIV) types 1-3 among pediatric outpatients with influenza-like illness (ILI).
Main Methods:
- Conducted surveillance of ILI patients from August 2010 to July 2014 across 13 U.S. states.
- Collected respiratory specimens from ILI patients and tested for PIV using RT-PCR.
- Calculated cumulative incidence based on provider patient populations.
Main Results:
- PIVs 1-3 were detected in 8.0% of 7716 ILI outpatient specimens; PIV3 was most common (44%).
- Incidence varied by year and type, with highest rates among children <5 years old.
- Median age at detection differed significantly between PIV types.
Conclusions:
- PIV types 1-3 cause a substantial proportion of medically attended pediatric ILI.
- Observed distinct seasonal circulation patterns and age-specific incidence rates for different PIV types.
Background:
Parainfluenza viruses (PIV) have been shown to contribute substantially to pediatric hospitalizations in the United States. However, to date, there has been no systematic surveillance to estimate the burden among pediatric outpatients.
Methods:
From August 2010 through July 2014, outpatient health care providers with enumerated patient populations in 13 states and jurisdictions participating in the Influenza Incidence Surveillance Project conducted surveillance of patients with influenza-like illness (ILI). Respiratory specimens were collected from the first 10 ILI patients each week with demographic and clinical data. Specimens were tested for multiple respiratory viruses, including PIV1-4, using reverse transcriptase-polymerase chain reaction assays. Cumulative incidence was calculated using provider patient population size as the denominator.
Results:
PIVs 1-3 were detected in 8.0% of 7716 ILI-related outpatient specimens: 30% were PIV1, 26% PIV2 and 44% PIV3. PIV circulation varied noticeably by year and type, with PIV3 predominating in 2010-2011 (incidence 110 per 100,000 children), PIV1 in 2011-2012 (89 per 100,000), dual predominance of PIV2 and PIV3 (88 and 131 per 100,000) in 2012-2013 and PIV3 (100 per 100,000) in 2013-2014. The highest incidence of PIV detections was among patients aged <5 years (259-1307 per 100,000). The median age at detection for PIV3 (3.4 years) was significantly lower than the median ages for PIV1 (4.5 years) and PIV2 (7.0 years; P < 0.05).
Conclusions:
PIVs 1-3 comprise a substantial amount of medically attended pediatric ILI, particularly among children aged <5 years. Distinct seasonal circulation patterns as well as significant differences in rates by age were observed between PIV types.
Related Concept Videos
Influenza
Infectious Diseases and Their Occurrence
Principles of Disease Surveillance

